by Jon Fleetwood, Jon Fleetwood:
New ‘Nature Communications’ study shows U.S. military and health agencies bankroll GOF experiments giving flu stronger ability to multiply and to suppress competing natural influenza viruses.
DARPA- and NIH-funded scientists published a study on Tuesday in which they claim to have enhanced the defective parts of the influenza genome with new replication and competition-suppressing functions, transforming previously dormant components of influenza into more powerful ones.
TRUTH LIVES on at https://sgtreport.tv/
The revelation comes as U.S. taxpayers fund research behind Moderna’s new mRNA-1010 (MFLUSIVA) influenza vaccine, raising questions about why Americans are funding both the manipulation of pathogens linked to outbreaks as well as the injectable “solution” to those outbreaks at the same time.
In the years before the COVID-19 pandemic, DARPA (Defense Advanced Research Projects Agency) was working with Moderna on an mRNA coronavirus vaccine, while at the same time working with EcoHealth on how to engineer coronaviruses with a furin cleavage site, human-optimized receptor binding domain, and two-proline spike mutation—the defining characteristics of what would be the COVID-19 virus.
Published in Nature Communications, the new study focused on what researchers call deletion-containing viral genomes (DelVGs)—defective pieces of influenza that contain large deletions in essential viral genes.
According to the authors, these influenza-derived genetic elements are defective because they “cannot replicate independently.”
In other words, the researchers were not claiming to be working with normal influenza genomes.
They were working with defective ones.
Rather than leaving those defective influenza elements unchanged, the researchers say they experimentally enhanced them.
The paper states that a specific modification “significantly enhances DelVG replication and interference potency.”
Those are the study’s words.
Enhanced replication.
Enhanced interference potency.
The authors further reported that the modification “enhances the replication and intracellular competitive advantage” of the defective influenza genome.
In plain English, scientists took defective influenza genetic elements and made them better at replicating and better at competing.
You can contact NIAID here, NIH here, and HHS here to voice opposition to taxpayer-funded research on pandemic pathogens—particularly after Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) all acknowledged that the COVID-19 pandemic was “likely” the result of a laboratory incident involving engineered pathogens.
Read More @ jonfleetwood.substack.com
